Since RB1 expression did not fully compensate the promotive effects of miR-661 on EMT, we can not rule out the possibility that miR-661 influenced other pathway to furnish EMT and metastasis of NSCLC. This evidence concerns the gene RB1 and non-small cell lung carcinoma.